|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Huang-Chien, Liang | Huang-Chien, Liang | Yi-Chun, Su | 03-6107168 | 1F., No.26, Sec. 2, Shengyi Rd.Zhubei City, 30261, Taiwan (R.O.C.) | 2021/01/25 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Wiltrom Co., Ltd. is dedicated in R&D and manufacturing of medical devices. The development of products is strongly focused on innovation and to create a highly competitive private brand in the global market. Wiltrom’s expertise including Biodegradable Materials, Implantable Medical Devices and MIS(Minimal Invasive Surgery) Instruments. We are aiming to provide the total solution of Spinal Fixation Surgery and Vertebral Compression Fracture. Our product portfolio is including spinal fixation system, interbody fusion system, synthetic bone graft substitute, vertebral body augmentation system and bone cement. With the momentum of being innovation, Wiltrom is committed to providing the best products and technologies to our partners to rest of the world. |
Market Information ( 2023/09/28 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
27.503 | 39.60 | 39.15 | 39.30 | -0.65 | 34 | N/A | N/A | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2023/09/28) |
TPEx measures adopted (2023/09/28) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
![]() |
![]() |
![]() |